All-cause mortality risk of metabolically healthy abdominal obese individuals: The EPIC-MORGEN study

Obesity

Volumn 22, Issue 2, 2014, Pages 557-564

  Van Der Daphne, L A ^a   Nooyens, Astrid C J ^a   Van Duijnhoven, Fränzel J B ^a,b   Verschuren, Monique M W ^a   Boer, Jolanda M A ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BODY MASS INDEX; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; OBESITY; OBESITY, ABDOMINAL; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84895904019     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20480     Document Type: Article

References (40)

1. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. WHO Technical Report Series no.894; 1999.
2. Blokstra A, Vissink P, Venmans LMAJ, et al. Measuring the Netherlands. A Monitoring Study of Risk Factors in the General Population, 2009-2010. RIVM Report no. 260152001; 2011.
3. Karelis AD, St Pierre DH, Conus F, et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89: 2569-2575.
4. Bluher M,. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010; 21: 38-43.
5. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981.
6. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34: 210-215.
7. Wildman RP,. Healthy obesity. Curr Opin Clin Nutr Metab Care 2009; 12: 438-443.
8. Velho S, Paccaud F, Waeber G, et al. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010; 64: 1043-1051.
9. Jacobs EJ, Newton CC, Wang Y, et al. Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med 2010; 170: 1293-1301.
10. Leitzmann MF, Moore SC, Koster A, et al. Waist circumference as compared with body-mass index in predicting mortality from specific causes. PLoS One 2011; 6: e18582.
11. Beulens JW, Monninkhof EM, Verschuren WM, et al. Cohort profile: the EPIC-NL study. Int J Epidemiol 2010; 39: 1170-1178.
12. Verschuren WM, Blokstra A, Picavet HS, et al. Cohort profile: the doetinchem cohort study. Int J Epidemiol 2008; 37: 1236-1241.
13. Ocke MC, Bueno-de-Mesquita HB, Goddijn HE, et al. The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 1997; 26 (Suppl 1): S37-S48.
14. Ocke MC, Bueno-de-Mesquita HB, Pols MA, et al. The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients. Int J Epidemiol 1997; 26 (Suppl 1): S49-S58.
15. Nevo Foundation. Dutch food composition table (Nederlands Voedingsstoffenbestand, NEVO table). Dutch Nutrition Center (Voedingscentrum/ Voorlichtingsbureau voor de Voeding). The Hague: 1996.
16. Pols MA, Peeters PH, Ocke MC, et al. Relative validity and repeatability of a new questionnaire on physical activity. Prev Med 1997; 26: 37-43.
17. Voorrips LE, Ravelli AC, Dongelmans PC, et al. A physical activity questionnaire for the elderly. Med Sci Sports Exerc 1991; 23: 974-979.
18. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003; 6: 407-413.
19. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005; 112: 2735-2752.
20. Smulders YM, Burgers JS, Scheltens T, et al. Clinical practice guideline for cardiovascular risk management in the Netherlands. Neth J Med 2008; 66: 169-174.
21. Rutten GEHM, De Grauw WJC, Nijpels G, et al. NHG-standaard diabetes mellitus type 2. Tweede herziening. [Practice guideline 'Diabetes mellitus type 2' (second revision) of the Dutch College of General Practitioners]. Huisarts Wet 2006; 49: 137-152.
22. Kuk JL, Ardern CI,. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabet Care 2009; 32: 2297-2299.
23. Arnlov J, Ingelsson E, Sundstrom J, et al. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230-236.
24. Hamer M, Stamatakis E,. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482-2488.
25. Ortega FB, Lee DC, Katzmarzyk PT, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34: 389-397.
26. Abdullah A, Stoelwinder J, Shortreed S, et al. The duration of obesity and the risk of type 2 diabetes. Public Health Nutr 2011; 14: 119-126.
27. Janssen I, Katzmarzyk PT, Ross R,. Duration of overweight and metabolic health risk in American men and women. Ann Epidemiol 2004; 14: 585-591.
28. Manu P, Ionescu-Tirgoviste C, Tsang J, et al. Dysmetabolic signals in metabolically healthy obesity. Obes Res Clin Pract 2012; 6: e9-e20.
29. Janiszewski PM, Ross R,. Effects of weight loss among metabolically healthy obese men and women. Diabet Care 2010; 33: 1957-1959.
30. Shin MJ, Hyun YJ, Kim OY, et al. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 2006; 30: 1529-1534.
31. Karelis AD, Messier V, Brochu M, et al. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008; 51: 1752-1754.
32. Bobbioni-Harsch E, Pataky Z, Makoundou V, et al. From metabolic normality to cardiometabolic risk factors in subjects with obesity. Obesity (Silver Spring) 2012; 20: 2063-2069.
33. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-1624.
34. Karelis AD, Brochu M, Rabasa-Lhoret R,. Can we identify metabolically healthy but obese individuals (MHO)? Diabet Metab 2004; 30: 569-572.
35. Karelis AD, Rabasa-Lhoret R,. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabet Metab 2008; 34: 183-184.
36. Shea JL, Randell EW, Sun G,. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring) 2011; 19: 624-630.
37. Mora S, Rifai N, Buring JE, et al. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008; 118: 993-1001.
38. Moebus S, Gores L, Losch C, et al. Impact of time since last caloric intake on blood glucose levels. Eur J Epidemiol 2011; 26: 719-728.
39. Snijder MB, van Dam RM, Visser M, et al. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92.
40. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020-1025.